USPTO 2015–2025 USPTO PatentsView Foreign Corporation

TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz

USPTO PatentsView assignee record - 62 granted patents across 16 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Tron—translationale ranks #5,557 of 49,997 tracked US assignees by granted-patent volume, with 62 patents across 16 technology areas.

#5,557
of 49,997 US assignees by volume
Top 18%
by Innovation Score (47.7/100)
21.8
avg claims per patent
+246%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5557 · Foreign Corporation #5,557 · 62 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 62 grants
  • UPPER-Q #5,557/49,997
  • PHOTO-FINISH Scientific Drilling…
  • CPC-FOCUS A61K · 16 areas
  • INNOV-PAR 47.7/100
  • CLAIMS-DENSE 21.8 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +246% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Scientific Drilling International, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Tron—translationale’s 47.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Tron—translationale

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Tron—translationale's Innovation Score is 47.7/100 (top 18% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Tron—translationale?

Each dot is one of Tron—translationale’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Tron—translationale’s own 21.8 claims/patent is ABOVE the 18.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Tron—translationale vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 61.962.062.06262.062.062.1 510152025 Granted patents (volume) Avg claims / patent Sungwoo Hitech Co., Ltd. - 62, 10.45Sungwoo HitechScientific Drilling International, Inc. - 62, 24.18Scientific Drilli…Synthetic Genomics, Inc. - 62, 20.4Synthetic GenomicsTaiwan Textile Research Institute - 62, 10.13Taiwan Textile Re…Trumpf Laser GMBH - 62, 18.94Trumpf LaserTeledyne Flir Commercial Systems, Inc. - 62, 18.02Teledyne Flir Com…The Babcock & Wilcox Company - 62, 21.52The Babcock & Wil…Typhon Technology Solutions (U.S.), LLC - 62, 20.32Typhon Technology…TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz - 62, 21.82TRON—Translationa…
Tron—translationale vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Tron—translationale's grants concentrate

TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz is a focused PatentsView assignee: 16 CPC subclasses with 83.9% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (15 grants) versus a trough of 1 in 2017. By volume, Tron—translationale sits between Sungwoo Hitech Co., Ltd. and Typhon Technology Solutions (U.S.), LLC.

Tron—translationale's three-year grant acceleration

From 2019–2021 to 2022–2024, TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz moved from 25 to 23 grants (0.92x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at TRON—Translationale's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows TRON—Translationale holds 62 patents at rank #5,553, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near TRON—Translationale

By rank, the assignees closest to #5,553 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in TRON—Translationale's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for TRON—Translationale, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), TRON—Translationale ranks #414 of 7,163 assignees by patent count in that subclass.

Tron—translationale's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 18% higher than 82% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 2016201720182019202020212022202320242025 4
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 4 6.5%
2017 1 1.6%
2018 5 8.1%
2019 3 4.8%
2020 15 24.2%
2021 7 11.3%
2022 10 16.1%
2023 6 9.7%
2024 7 11.3%
2025partial year 4 6.5%

Which technologies does TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz patent most?

Top 15 of 16 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz's patent record in context - here's where to go next.

  • TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 83.9% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #5,557 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz against Sungwoo Hitech Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 47.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.